In collaboration with The Rosalind Franklin Institute, we have been detecting a tiny peptide that could diagnose Alzheimer’s disease at an early stage, an SME focusing on therapeutics for neurodegenerative disease. Together, we were able to use our Mass Spectrometry...
Neuro-Bio’s CSO, Sara Garcia-Rates was excited to visit the university and be a part of the panel of the careers event, where she shared her experience of her career development and insight of the bio-tech industry. The panel was then followed by a...
Why do we celebrate this? – To inspire and engage others to pursue science, technology, engineering, and mathematics – To improve gender equality in science – To highlight the role of women and girls in science and technology communities – To...
Our latest study, published in Neurobiology of Aging, investigates the role of the novel peptide T14 in age-dependent behaviours using female mice models. The findings highlight significant variations in T14 levels with age, shedding light on potential mechanisms...
Their final episode of season two rounded out the theme of prevention by focusing on an area of significant impact for many of us personally and professionally. Baroness Susan Greenfield (Neuro-Bio Ltd) spoke about and explored the possibilities for preventing...
“In six months we will have the test for Alzheimer’s, and in two months, the cure!” Baroness Greenfield talks about Alzheimer’s Disease, and the focus on discovering a test and a cure! To read the full interview, with the option to translate,...
